The position of vitamin D within the cardiovascular system is complicated as a result of it regulates expression of genes concerned in various metabolic processes. Though known as a vitamin, it’s extra precisely thought of a steroid hormone, as a result of it’s produced endogenously within the presence of ultraviolet mild. It happens as a collection of sequentially activated varieties, right here known as vitamin D-hormones. Slightly-known phenomenon, primarily based on pre-clinical information, is that its biodistribution and potential results on vascular illness doubtless rely upon whether or not it’s derived from weight-reduction plan or daylight.
Weight loss program-derived vitamin D-hormones are carried within the blood, at the least partly, in chylomicrons and lipoprotein particles, together with LDL. Since LDL is understood to build up within the artery wall and atherosclerotic plaque, diet-derived vitamin D-hormones may acquire there, and presumably promote the osteochondrogenic mineralization related to plaque. Additionally, little recognized is the truth that the physique shops vitamin D-hormones in adipose tissue with a half-life on the order of months, elevating doubts about whether or not using the time period “day by day requirement” is suitable.
Cardiovascular results of vitamin D-hormones are controversial, and threat seems to extend with each high and low blood ranges. Since low serum vitamin D-hormone focus is reportedly related to elevated cardiovascular and orthopedic threat, oral supplementation is extensively used, usually along with calcium dietary supplements. Nonetheless, meta-analyses present that oral vitamin D-hormone supplementation doesn’t defend towards cardiovascular occasions, findings which are additionally supported by a randomized managed trial. These issues counsel that prevalent suggestions for vitamin D-hormone supplementation for the aim of cardiovascular safety must be rigorously reconsidered.
Utility of Coronary Artery Calcium Scores in Predicting Danger of Subclinical Cardiovascular Atherosclerotic Illness: An Evaluation of Limitations to its Adoption With Coverage Suggestions
This survey-based evaluation goals to spotlight key limitations to a wider adoption of coronary artery calcium (CAC) scoring as a way of screening asymptomatic people for atherosclerotic heart problems. The necessity for a screening device that provides goal anatomical info to traditionally established threat scores within the aforementioned inhabitants has been met by this imaging modality. Regardless of that, there was a hesitance in the direction of frequent utilization of those scans.
Inside the pre-set sampling body of the College of Toledo, a comfort sampling method was used to succeed in out to 60 well being care suppliers. The resultant responses had been analyzed and mentioned. Along with figuring out sufferers who have to be labored up additional, CAC scans can even assist re-stratify sufferers within-risk teams and inform decision-making concerning using lipid-lowering therapies. The general public well being affect of a better however applicable utilization of this diagnostic device shall be impactful. This evaluation seeks to higher perceive real-life obstacles to a wider adoption of those scans and makes an attempt to put out coverage suggestions to deal with these points.
Impression of DAA Remedy on Cardiovascular Illness Danger in Continual HCV An infection: An Replace
Hepatitis C virus (HCV) an infection is a systemic illness related to a number of vital extrahepatic manifestations. Rising research point out affiliation between the HCV an infection and a better incidence of main opposed cardiovascular occasions akin to: coronary artery illness, coronary heart failure, stroke and peripheral artery illness, when in comparison with normal inhabitants. Atherosclerosis is a typical pathophysiologic mechanism of heart problems (CVD) improvement which is the main reason for mortality within the Western world. Proposed mechanisms of HCV-induced atherosclerosis consists of systemic irritation as a result of continual an infection with elevated ranges of pro-atherogenic cytokines and chemokines.

Moreover, it has been demonstrated that HCV exists and replicates inside atheroschlerotic plaques, supporting the speculation of direct pro-atherogenic impact of the virus. Direct appearing antiviral brokers (DAAs) signify a secure and extremely efficient therapy of HCV an infection. Beside the advance in liver-related outcomes, DAAs exhibit a helpful impact on extra-hepatic manifestations of continual HCV an infection. Lately, it has been proven that sufferers with continual HCV an infection handled with DAA-based therapeutic regimes had a 43% discount of CVD occasions incidence threat.
Furthermore, eradication of HCV with DAAs leads to a big optimistic impact on threat elements for heart problems, regardless of a normal worsening of the lipid profile. This optimistic results is especially because of an enchancment of endothelial perform and glucose metabolism. Though DAA therapy is related to a helpful affect on cardiovascular occasions, additional research are wanted to totally elucidate the mechanisms accountable.
COVID-19 and Cardiovascular Ailments: Challenges and Options
Rampantly spreading across the globe and taking hundreds of lives every day, coronavirus illness 2019 (COVID-19) could current with different cardiovascular manifestations. These with proof of myocardial harm have a worse prognosis too. Sufferers with pre-existing cardiovascular ailments or threat elements are at better threat of opposed outcomes and mortality by this an infection.
HEY2 Antibody |
|
34094 |
SAB |
100ul |
EUR 319 |
HEY2 Antibody |
|
34094-100ul |
SAB |
100ul |
EUR 302.4 |
HEY2 Antibody |
|
34094-50ul |
SAB |
50ul |
EUR 224.4 |
hey2 Antibody |
|
CSB-PA872778XA01DIL-02mg |
Cusabio |
0.2mg |
Ask for price |
|
|
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) hey2 protein |
hey2 Antibody |
|
CSB-PA872778XA01DIL-10mg |
Cusabio |
10mg |
Ask for price |
|
|
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) hey2 protein |
HEY2 Antibody |
|
CSB-PA883365XA01HU-02mg |
Cusabio |
0.2mg |
Ask for price |
|
|
|
Description: Recombinant Homo sapiens (Human) HEY2 protein |
HEY2 Antibody |
|
CSB-PA883365XA01HU-10mg |
Cusabio |
10mg |
Ask for price |
|
|
|
Description: Recombinant Homo sapiens (Human) HEY2 protein |
HEY2 Antibody |
|
1-CSB-PA010321GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against HEY2. Recognizes HEY2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
HEY2 Antibody |
|
1-CSB-PA008379 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
|
|
Description: A polyclonal antibody against HEY2. Recognizes HEY2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
HEY2 Antibody |
|
CSB-PA993153- |
Cusabio |
each |
EUR 402 |
|
|
|
Description: A polyclonal antibody against HEY2. Recognizes HEY2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
HEY2 Antibody |
|
CSB-PA993153-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
|
|
Description: A polyclonal antibody against HEY2. Recognizes HEY2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
HEY2 Antibody |
|
E11-11818C |
EnoGene |
100μg |
EUR 225 |
|
Description: Available in various conjugation types. |
HEY2 Antibody |
|
E034094 |
EnoGene |
100μg/100μl |
EUR 255 |
|
Description: Available in various conjugation types. |
HEY2 Antibody |
|
E309142 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
HEY2 Antibody |
|
MBS7130988-01mL |
MyBiosource |
0.1mL |
EUR 270 |
HEY2 Antibody |
|
MBS7130988-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
HEY2 Antibody |
|
MBS7119238-005mg |
MyBiosource |
0.05mg |
EUR 150 |
HEY2 Antibody |
|
MBS7119238-01mg |
MyBiosource |
0.1mg |
EUR 190 |
HEY2 Antibody |
|
MBS7119238-5x01mg |
MyBiosource |
5x0.1mg |
EUR 845 |
HEY2 Antibody |
|
MBS851847-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
HEY2 Antibody |
|
MBS851847-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
HEY2 Antibody |
|
MBS851847-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
HEY2 Antibody |
|
MBS851847-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
HEY2 Antibody |
|
MBS9505513-005mL |
MyBiosource |
0.05mL |
EUR 285 |
HEY2 Antibody |
|
MBS9505513-01mL |
MyBiosource |
0.1mL |
EUR 385 |
HEY2 Antibody |
|
MBS9505513-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
HEY2 Antibody |
|
MBS9412353-005mL |
MyBiosource |
0.05mL |
EUR 245 |
HEY2 Antibody |
|
MBS9412353-01mL |
MyBiosource |
0.1mL |
EUR 305 |
HEY2 Antibody |
|
MBS9412353-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1230 |
HEY2 Rabbit pAb |
|
A15143 |
Abclonal |
500μL |
EUR 173.58 |
HEY2 Rabbit pAb |
|
A15143-100ul |
Abclonal |
100 ul |
EUR 369.6 |
HEY2 Rabbit pAb |
|
A15143-200ul |
Abclonal |
200 ul |
EUR 550.8 |
HEY2 Rabbit pAb |
|
A15143-20ul |
Abclonal |
20 ul |
EUR 219.6 |
HEY2 Rabbit pAb |
|
A15143-50ul |
Abclonal |
50 ul |
EUR 267.6 |
HEY2 cDNA Clone |
|
MBS1275255-001mgPlasmid02mLGlycerolStock |
MyBiosource |
0.01mgPlasmid+0.2mLGlycerol-Stock |
EUR 350 |
HEY2 cDNA Clone |
|
MBS1275255-5x001mgPlasmid5x02mLGlycerolStock |
MyBiosource |
5x0.01mgPlasmid+5x0.2mLGlycerol-Stock |
EUR 1530 |
HEY2 Rabbit pAb |
|
E45R21694N |
EnoGene |
50 ul |
EUR 297.75 |
Mouse HEY2 siRNA |
|
20-abx919306 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Human HEY2 siRNA |
|
20-abx919307 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
HEY2 siRNA (Human) |
|
MBS8201774-15nmol |
MyBiosource |
15nmol |
EUR 405 |
HEY2 siRNA (Human) |
|
MBS8201774-30nmol |
MyBiosource |
30nmol |
EUR 565 |
HEY2 siRNA (Human) |
|
MBS8201774-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
HEY2 siRNA (Mouse) |
|
MBS8206871-15nmol |
MyBiosource |
15nmol |
EUR 405 |
HEY2 siRNA (Mouse) |
|
MBS8206871-30nmol |
MyBiosource |
30nmol |
EUR 565 |
HEY2 siRNA (Mouse) |
|
MBS8206871-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
anti- HEY2 antibody |
|
FNab03850 |
FN Test |
100µg |
EUR 606.3 |
|
|
|
Description: Antibody raised against HEY2 |
DANRE hey2 Antibody |
|
abx034877-100g |
Abbexa |
100 µg |
EUR 281.25 |
DANRE hey2 Antibody |
|
abx034877-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
DANRE hey2 Antibody |
|
abx034877-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
HEY2 cloning plasmid |
|
CSB-CL883365HU-10ug |
Cusabio |
10ug |
EUR 472.8 |
|
|
|
Description: A cloning plasmid for the HEY2 gene. |
HEY2 Blocking Peptide |
|
MBS8244224-1mg |
MyBiosource |
1mg |
EUR 190 |
HEY2 Blocking Peptide |
|
MBS8244224-5mg |
MyBiosource |
5mg |
EUR 345 |
HEY2 Blocking Peptide |
|
MBS8244224-5x5mg |
MyBiosource |
5x5mg |
EUR 1465 |
Recombinant Human HEY2 |
|
MBS7613096-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human HEY2 |
|
MBS7613096-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human HEY2 |
|
MBS7613096-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human HEY2 |
|
MBS7613096-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
HEY2 Immunizing Peptide |
|
MBS427319-01mg |
MyBiosource |
0.1mg |
EUR 225 |
HEY2 Polyclonal Antibody |
|
E-AB-91051-120uL |
Elabscience Biotech |
120uL |
EUR 320 |
|
|
|
Description: Unconjugated |
HEY2 Polyclonal Antibody |
|
E-AB-91051-200uL |
Elabscience Biotech |
200uL |
EUR 530 |
|
|
|
Description: Unconjugated |
HEY2 Polyclonal Antibody |
|
E-AB-91051-60uL |
Elabscience Biotech |
60uL |
EUR 200 |
|
|
|
Description: Unconjugated |
HEY2 Polyclonal Antibody |
|
E-AB-91051-each |
Elabscience Biotech |
each |
Ask for price |
|
|
|
Description: Unconjugated |
HEY2 Conjugated Antibody |
|
C34094 |
SAB |
100ul |
EUR 476.4 |
HEY2 polyclonal antibody |
|
BS76146 |
Bioworld Biotech |
50ul |
EUR 358 |
|
|
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
HEY2 Polyclonal Antibody |
|
E915143 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
HEY2 Polyclonal Antibody |
|
MBS9135129-002mL |
MyBiosource |
0.02mL |
EUR 200 |
HEY2 Polyclonal Antibody |
|
MBS9135129-005mL |
MyBiosource |
0.05mL |
EUR 255 |
HEY2 Polyclonal Antibody |
|
MBS9135129-01mL |
MyBiosource |
0.1mL |
EUR 345 |
HEY2 Polyclonal Antibody |
|
MBS9135129-02mL |
MyBiosource |
0.2mL |
EUR 545 |
HEY2 Polyclonal Antibody |
|
MBS9135129-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2265 |
HEY2 Polyclonal Antibody |
|
MBS8569828-01mL |
MyBiosource |
0.1mL |
EUR 305 |
HEY2 Polyclonal Antibody |
|
MBS8569828-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
HEY2 Polyclonal Antibody |
|
MBS8569828-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
HEY2 Polyclonal Antibody |
|
MBS8569828-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
HEY2 Polyclonal Antibody |
|
MBS8569828-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
HEY2 Conjugated Antibody |
|
MBS9444950-01mLAF350 |
MyBiosource |
0.1mL(AF350) |
EUR 480 |
HEY2 Conjugated Antibody |
|
MBS9444950-01mLAF405 |
MyBiosource |
0.1mL(AF405) |
EUR 480 |
HEY2 Conjugated Antibody |
|
MBS9444950-01mLAF488 |
MyBiosource |
0.1mL(AF488) |
EUR 480 |
HEY2 Conjugated Antibody |
|
MBS9444950-01mLAF555 |
MyBiosource |
0.1mL(AF555) |
EUR 480 |
HEY2 Conjugated Antibody |
|
MBS9444950-01mLBiotin |
MyBiosource |
0.1mL(Biotin) |
EUR 480 |
HEY2 Antibody (N-term) |
|
E45R32214G-1 |
EnoGene |
100 ul |
EUR 395 |
HEY2 Antibody (N-term) |
|
E45R32214G-4 |
EnoGene |
50 ul |
EUR 295 |
HEY2 Antibody (N-term) |
|
MBS9207265-008mL |
MyBiosource |
0.08mL |
EUR 210 |
HEY2 Antibody (N-term) |
|
MBS9207265-04mL |
MyBiosource |
0.4mL |
EUR 430 |
HEY2 Antibody (N-term) |
|
MBS9207265-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
Human HEY2 shRNA Plasmid |
|
20-abx958304 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Mouse HEY2 shRNA Plasmid |
|
20-abx970786 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Anti-HRT2 HEY2 Antibody |
|
A03035 |
BosterBio |
100ul |
EUR 380 |
|
|
|
Description: Boster Bio Anti-HRT2 HEY2 Antibody catalog # A03035. Tested in ELISA, IHC, WB applications. This antibody reacts with Human, Mouse. |
Human HEY2 Protein Lysate |
|
MBS8412898-002mg |
MyBiosource |
0.02mg |
EUR 365 |
Human HEY2 Protein Lysate |
|
MBS8412898-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1410 |
HEY2 (NM_012259) Human Recombinant Protein |
|
E45H40809M5 |
EnoGene |
20 ug |
EUR 785.42 |
Hey2 (NM_013904) Mouse Recombinant Protein |
|
E45M43066M5 |
EnoGene |
20 ug |
EUR 1924.54 |
HEY2 (NM_012259) Human Recombinant Protein |
|
PROTQ9UBP5 |
BosterBio |
20ug |
EUR 1249 |
|
Description: Recombinant protein of human hairy/enhancer-of-split related with YRPW motif 2 (HEY2) |
HEY2 Peptide - middle region |
|
MBS3229346-01mg |
MyBiosource |
0.1mg |
EUR 180 |
HEY2 Peptide - middle region |
|
MBS3229346-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
HEY2 antibody - middle region |
|
MBS3204379-01mL |
MyBiosource |
0.1mL |
EUR 455 |
HEY2 antibody - middle region |
|
MBS3204379-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
HEY2 Recombinant Protein (Rat) |
|
RP204494 |
ABM |
100 ug |
Ask for price |
HEY2 Recombinant Protein (Human) |
|
RP014611 |
ABM |
100 ug |
Ask for price |
HEY2 Recombinant Protein (Mouse) |
|
RP141377 |
ABM |
100 ug |
Ask for price |
Hey2 ORF Vector (Rat) (pORF) |
|
ORF068166 |
ABM |
1.0 ug DNA |
EUR 607.2 |
HEY2 (untagged)-Human hairy/enhancer-of-split related with YRPW motif 2 (HEY2) |
|
SC303947 |
Origene Technologies GmbH |
10 µg |
Ask for price |
HEY2 ORF Vector (Human) (pORF) |
|
ORF004871 |
ABM |
1.0 ug DNA |
EUR 114 |
Hey2 ORF Vector (Mouse) (pORF) |
|
ORF047127 |
ABM |
1.0 ug DNA |
EUR 607.2 |
HEY2 (NM_012259) Human Over-expression Lysate |
|
E45H18285-2 |
EnoGene |
20 ug |
EUR 395 |
HEY2 (NM_012259) Human Over-expression Lysate |
|
LS023493 |
BosterBio |
100ug |
EUR 628 |
|
|
|
Description: Transient overexpression lysate of hairy/enhancer-of-split related with YRPW motif 2 (HEY2) |
DANRE hey2 Antibody (C-term) |
|
MBS9201839-008mL |
MyBiosource |
0.08mL |
EUR 210 |
DANRE hey2 Antibody (C-term) |
|
MBS9201839-04mL |
MyBiosource |
0.4mL |
EUR 430 |
DANRE hey2 Antibody (C-term) |
|
MBS9201839-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
Human HEY2 knockout cell line |
|
ABC-KH6720 |
AcceGen |
1 vial |
Ask for price |
|
Description: Human HEY2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HEY2 knockdown cell line |
|
ABC-KD6720 |
AcceGen |
1 vial |
Ask for price |
|
Description: Human HEY2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human HEY2 Protein Lysate 20ug |
|
IHUHEY2PLLY20UG |
Innovative research |
each |
EUR 213 |
|
|
|
Description: Human HEY2 Protein Lysate 20ug |
HEY2 Peptide - N-terminal region |
|
MBS3248258-01mg |
MyBiosource |
0.1mg |
EUR 180 |
HEY2 Peptide - N-terminal region |
|
MBS3248258-5x01mg |
MyBiosource |
5x0.1mg |
EUR 730 |
Zebrafish hey2 Antibody (C-term) |
|
MBS9216635-005mL |
MyBiosource |
0.05mL |
EUR 210 |
Zebrafish hey2 Antibody (C-term) |
|
MBS9216635-02mL |
MyBiosource |
0.2mL |
EUR 430 |
Zebrafish hey2 Antibody (C-term) |
|
MBS9216635-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1910 |
HEY2 Antibody (N-term) [APR32214G] |
|
APR32214G |
Leading Biology |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 50 µL
- 100 µL
- 200 µL
- 400 µL
|
|
|
HEY2 Antibody - N-terminal region |
|
MBS3223649-01mL |
MyBiosource |
0.1mL |
EUR 455 |
HEY2 Antibody - N-terminal region |
|
MBS3223649-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1995 |
Hey2 (untagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2), (10ug) |
|
MC208661 |
Origene Technologies GmbH |
10 µg |
Ask for price |
HEY2 (GFP-tagged) - Human hairy/enhancer-of-split related with YRPW motif 2 (HEY2) |
|
RG202544 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Anti Human HEY2 Polyclonal Antibody |
|
Y054703 |
ABM |
100 µl |
EUR 575 |
HEY2 Over-expression Lysate Product |
|
GWB-99BF56 |
GenWay Biotech |
0.1 mg |
Ask for price |
DANRE hey2 Rabbit Polyclonal Antibody |
|
E10G32527 |
EnoGene |
100 μl |
EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Hey2 (untagged) - Rat hes-related family bHLH transcription factor with YRPW motif 2 (Hey2) |
|
RN216405 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Polyclonal HEY2 Antibody (internal region) |
|
APG00686G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human HEY2 (internal region). This antibody is tested and proven to work in the following applications: |
Hey2 (GFP-tagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2), (10ug) |
|
MG223872 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Hey2 (Myc-DDK-tagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2) |
|
MR223872 |
Origene Technologies GmbH |
10 µg |
Ask for price |
HEY2 (Myc-DDK-tagged)-Human hairy/enhancer-of-split related with YRPW motif 2 (HEY2) |
|
RC202544 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Hey2 (C-term)(DANRE) Rabbit pAb |
|
E2617405 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
HEY2 (C-Term) (DANRE) Rabbit pAb |
|
MBS8555794-01mL |
MyBiosource |
0.1mL |
EUR 305 |
HEY2 (C-Term) (DANRE) Rabbit pAb |
|
MBS8555794-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
HEY2 (C-Term) (DANRE) Rabbit pAb |
|
MBS8555794-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
HEY2 (C-Term) (DANRE) Rabbit pAb |
|
MBS8555794-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
HEY2 (C-Term) (DANRE) Rabbit pAb |
|
MBS8555794-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
Zebrafish hey2 (C-term) Rabbit pAb |
|
E2620231 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
Zebrafish HEY2 (C-Term) Rabbit pAb |
|
MBS8558487-01mL |
MyBiosource |
0.1mL |
EUR 305 |
Zebrafish HEY2 (C-Term) Rabbit pAb |
|
MBS8558487-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
Zebrafish HEY2 (C-Term) Rabbit pAb |
|
MBS8558487-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
Zebrafish HEY2 (C-Term) Rabbit pAb |
|
MBS8558487-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
Zebrafish HEY2 (C-Term) Rabbit pAb |
|
MBS8558487-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
Hey2 sgRNA CRISPR Lentivector set (Rat) |
|
K7021301 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
HEY2 sgRNA CRISPR Lentivector set (Human) |
|
K0948301 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Hey2 sgRNA CRISPR Lentivector set (Mouse) |
|
K4472801 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
HEY2 Antibody (N-term) Blocking peptide |
|
MBS9225847-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
HEY2 (N-term) Rabbit Polyclonal Antibody |
|
E10G34953 |
EnoGene |
100 μl |
EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Hey2 (myc-DDK-tagged) - Rat hes-related family bHLH transcription factor with YRPW motif 2 (Hey2) |
|
RR216405 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Hey2 3'UTR GFP Stable Cell Line |
|
TU255747 |
ABM |
1.0 ml |
Ask for price |
Hey2 3'UTR GFP Stable Cell Line |
|
TU159477 |
ABM |
1.0 ml |
Ask for price |
HEY2 3'UTR GFP Stable Cell Line |
|
TU059746 |
ABM |
1.0 ml |
EUR 1672.8 |
ARP38979_P050 - HEY2 antibody - middle region (ARP38979_P050) |
|
ARP38979_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
|
HEY2 Protein Vector (Rat) (pPM-C-HA) |
|
PV272664 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Rat) (pPB-C-His) |
|
PV272662 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Rat) (pPB-N-His) |
|
PV272663 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Rat) (pPM-C-His) |
|
PV272665 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Mouse) (pPM-C-HA) |
|
PV188508 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Human) (pPM-C-HA) |
|
PV019483 |
ABM |
500 ng |
EUR 394.8 |
HEY2 Protein Vector (Mouse) (pPB-C-His) |
|
PV188506 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Mouse) (pPB-N-His) |
|
PV188507 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Mouse) (pPM-C-His) |
|
PV188509 |
ABM |
500 ng |
EUR 723.6 |
HEY2 Protein Vector (Human) (pPB-C-His) |
|
PV019481 |
ABM |
500 ng |
EUR 394.8 |
HEY2 Protein Vector (Human) (pPB-N-His) |
|
PV019482 |
ABM |
500 ng |
EUR 394.8 |
HEY2 Protein Vector (Human) (pPM-C-His) |
|
PV019484 |
ABM |
500 ng |
EUR 394.8 |
Hey2 3'UTR Luciferase Stable Cell Line |
|
TU109477 |
ABM |
1.0 ml |
Ask for price |
Hey2 3'UTR Luciferase Stable Cell Line |
|
TU205747 |
ABM |
1.0 ml |
Ask for price |
HEY2 3'UTR Luciferase Stable Cell Line |
|
TU009746 |
ABM |
1.0 ml |
EUR 1672.8 |
Lenti ORF clone of Hey2 (mGFP-tagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2) |
|
MR223872L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Hey2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|
K7021302 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hey2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|
K7021303 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hey2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|
K7021304 |
ABM |
1.0 ug DNA |
EUR 184.8 |
HEY2 sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K0948302 |
ABM |
1.0 ug DNA |
EUR 184.8 |
HEY2 sgRNA CRISPR Lentivector (Human) (Target 2) |
|
K0948303 |
ABM |
1.0 ug DNA |
EUR 184.8 |
HEY2 sgRNA CRISPR Lentivector (Human) (Target 3) |
|
K0948304 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hey2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|
K4472802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hey2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|
K4472803 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hey2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|
K4472804 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Lenti ORF clone of Hey2 (Myc-DDK-tagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2) |
|
MR223872L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
ARP89416_P050-25UL - HEY2 Antibody - N-terminal region |
|
ARP89416_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
|
Lenti ORF particles, Hey2 (GFP-tagged) - Mouse hairy/enhancer-of-split related with YRPW motif 2 (Hey2), 200ul, >10^7 TU/mL |
|
MR223872L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, HEY2 (mGFP-tagged) - Human hairy/enhancer-of-split related with YRPW motif 2 (HEY2), 200ul, >10^7 TU/mL |
|
RC202544L2V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, HEY2 (mGFP-tagged) - Human hairy/enhancer-of-split related with YRPW motif 2 (HEY2), 200ul, >10^7 TU/mL |
|
RC202544L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
HEY2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|
LV626209 |
ABM |
1.0 ug DNA |
EUR 818.4 |
HEY2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|
LV626213 |
ABM |
1.0 ug DNA |
EUR 818.4 |
HEY2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|
LV626214 |
ABM |
1.0 ug DNA |
EUR 818.4 |
Being extremely contagious, measures to forestall cross-infection are of paramount significance. On this article, the authors summarize the varied cardiovascular manifestations of COVID-19 and precautions wanted whereas dealing with them and the long-term penalties of COVID-19 an infection.